Evaluation of suspected malignancies: Difference between revisions
Jump to navigation
Jump to search
→Staging: Size |
→Lymphovascular invasion: +Molecular |
||
| Line 143: | Line 143: | ||
</gallery> | </gallery> | ||
[[File:Histopathology of pancreatic adenocarcinoma with treatment effect.jpg|thumb|Also note "treatment effect", seen as fibroelastotic tissue, here with scattered remaining tumor cells.]] | [[File:Histopathology of pancreatic adenocarcinoma with treatment effect.jpg|thumb|Also note "treatment effect", seen as fibroelastotic tissue, here with scattered remaining tumor cells.]] | ||
==Molecular workup== | |||
Send samples according to requirements and guidelines for each test. For molecular proliferation tests (other than [[immunohistochemistry]]) such as Ki67, avoid samples with previous biopsy site or inflammation (as these will cause a false high proliferation rate). | |||
==Reporting== | ==Reporting== | ||